Passive Immunotherapy Against SARS-CoV-2: From Plasma-Based Therapy to Single Potent Antibodies in the Race to Stay Ahead of the Variants

The COVID-19 pandemic is now approaching 2 years old, with more than 440 million people infected and nearly six million dead worldwide, making it the most significant pandemic since the 1918 influenza pandemic. The severity and significance of SARS-CoV-2 was recognized immediately upon discovery, le...

Descripción completa

Detalles Bibliográficos
Autores principales: Strohl, William R., Ku, Zhiqiang, An, Zhiqiang, Carroll, Stephen F., Keyt, Bruce A., Strohl, Lila M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Leading Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9043892/
https://www.ncbi.nlm.nih.gov/pubmed/35476216
http://dx.doi.org/10.1007/s40259-022-00529-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9043892/
https://www.ncbi.nlm.nih.gov/pubmed/35476216
http://dx.doi.org/10.1007/s40259-022-00529-7

Ejemplares similares